GC Pharma Preps For Life After Sale Of North American Subsidiaries
Convalescent Plasma Among Key Projects
South Korean firm outlines R&D milestones for this year including progress with a plasma therapy for COVID-19, as well as other challenges and opportunities amid the pandemic.
